CD36 and neoplasm: Although recent studies suggest that PMN-MDSCs have a higher expression of lipid transport proteins such as CD36 [12, 13], little is known regarding the expression of these and other neutrophil markers at different anatomical sites relevant to cancer (e.g., tumor, TDLN, etc.), as well as their association with metastasis.